Fresenius Medical Care AG (NYSE:FMS) Shares Acquired by Millennium Management LLC

Millennium Management LLC grew its position in Fresenius Medical Care AG (NYSE:FMS - Free Report) by 5,297.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 722,238 shares of the company's stock after purchasing an additional 708,857 shares during the period. Millennium Management LLC owned approximately 0.12% of Fresenius Medical Care worth $16,351,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of FMS. ABC Arbitrage SA bought a new position in Fresenius Medical Care in the 4th quarter worth about $4,215,000. OLD Mission Capital LLC bought a new position in Fresenius Medical Care in the 4th quarter worth about $3,545,000. Broyhill Asset Management bought a new position in Fresenius Medical Care in the 4th quarter worth about $3,412,000. Integral Health Asset Management LLC grew its position in Fresenius Medical Care by 33.3% in the 4th quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company's stock worth $13,584,000 after purchasing an additional 150,000 shares during the last quarter. Finally, Northern Trust Corp grew its position in Fresenius Medical Care by 45.9% in the 4th quarter. Northern Trust Corp now owns 362,190 shares of the company's stock worth $8,200,000 after purchasing an additional 113,953 shares during the last quarter. Institutional investors own 8.37% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on FMS shares. Wall Street Zen started coverage on shares of Fresenius Medical Care in a research report on Tuesday, May 20th. They issued a "strong-buy" rating for the company. Truist Financial increased their price objective on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the company a "hold" rating in a report on Monday, May 12th. Finally, Morgan Stanley reiterated an "underweight" rating on shares of Fresenius Medical Care in a report on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Fresenius Medical Care presently has an average rating of "Hold" and an average price target of $27.80.

Fresenius Medical Care Price Performance

Shares of Fresenius Medical Care stock traded up $0.49 on Tuesday, hitting $29.51. The company had a trading volume of 297,087 shares, compared to its average volume of 327,175. The business has a 50-day simple moving average of $25.71 and a 200-day simple moving average of $24.13. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The company has a market cap of $17.32 billion, a PE ratio of 24.39, a PEG ratio of 0.76 and a beta of 0.85. Fresenius Medical Care AG has a 52 week low of $17.93 and a 52 week high of $30.46.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The business had revenue of $5.54 billion during the quarter, compared to analysts' expectations of $4.71 billion. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. Research analysts expect that Fresenius Medical Care AG will post 1.51 EPS for the current fiscal year.

Fresenius Medical Care Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Friday, June 6th. Investors of record on Friday, May 23rd will be paid a dividend of $0.7871 per share. The ex-dividend date of this dividend is Friday, May 23rd. This is a positive change from Fresenius Medical Care's previous annual dividend of $0.44. This represents a yield of 1.9%. Fresenius Medical Care's dividend payout ratio is currently 49.11%.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.